Literature DB >> 26574845

Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes.

Yaser R Hussein1, Jennifer A Ducie, Angela G Arnold, Noah D Kauff, Hebert A Vargas-Alvarez, Evis Sala, Douglas A Levine, Robert A Soslow.   

Abstract

Characteristic histopathologic features have been described in high-grade serous carcinoma associated with BRCA abnormalities (HGSC-BRCA), which are known to have relatively favorable clinical outcomes. The aim of this study was to evaluate the clinical significance of invasion patterns in metastatic HGSC-BRCA cases. Of the 37 cases of advanced-stage HGSC with known BRCA1 or BRCA2 germline mutation retrieved from our institutional files, 23 patients had a germline mutation of BRCA1 and 14 had a BRCA2 mutation. The pattern of invasion at metastatic sites was recorded and classified as a pushing pattern (either predominantly or exclusively), an exclusively micropapillary infiltrative pattern, or an infiltrative pattern composed of papillae, micropapillae, glands, and nests (mixed infiltrative pattern). Histologic evaluation of metastases was performed without knowledge of genotype or clinical outcome. Clinical data were abstracted from medical records. Median age was 56 years (range, 31 to 73 y). All patients presented at stage IIIC or IV and underwent complete surgical staging followed by chemotherapy. All 37 HGSC-BRCA cases showed either pushing pattern metastases (30; 81%) or infiltrative micropapillary metastases (7; 19%). No HGSC-BRCA case exhibited metastases composed solely of mixed infiltrative patterns. Among the 7 infiltrative micropapillary cases, 6 had a BRCA1 germline mutation versus 1 with a BRCA2 mutation. The median time of follow-up was 26 months (range, 13 to 49 mo). All 7 patients with infiltrative micropapillary metastases either experienced recurrence or died of disease (5 recurrences and 2 deaths), which was significantly worse than what was seen in patients with predominantly pushing pattern metastases, of whom 16 of 30 (53%) experienced recurrence (n=14) or died of disease (n=2) (P=0.03). In conclusion, the recognition of different invasion patterns of metastatic extrauterine HGSC-BRCA has prognostic implications. The infiltrative micropapillary pattern is associated with poor outcomes and is more frequently seen in BRCA1-associated HGSC than in BRCA2 cases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26574845      PMCID: PMC4970426          DOI: 10.1097/PAS.0000000000000556

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  22 in total

1.  Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma.

Authors:  Brooke E Howitt; Suchanan Hanamornroongruang; Douglas I Lin; James E Conner; Stephanie Schulte; Neil Horowitz; Christopher P Crum; Emily E Meserve
Journal:  Am J Surg Pathol       Date:  2015-03       Impact factor: 6.394

2.  Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.

Authors:  Hebert Alberto Vargas; Maura Miccò; Seong Im Hong; Debra A Goldman; Fanny Dao; Britta Weigelt; Robert A Soslow; Hedvig Hricak; Douglas A Levine; Evis Sala
Journal:  Radiology       Date:  2014-11-10       Impact factor: 11.105

3.  Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.

Authors:  Robert A Soslow; Guangming Han; Kay J Park; Karuna Garg; Narciso Olvera; David R Spriggs; Noah D Kauff; Douglas A Levine
Journal:  Mod Pathol       Date:  2011-12-23       Impact factor: 7.842

4.  Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study.

Authors:  Andrea Diaz De Vivar; Andres A Roma; Kay J Park; Isabel Alvarado-Cabrero; Golnar Rasty; Jose G Chanona-Vilchis; Yoshiki Mikami; Sung R Hong; Brent Arville; Norihiro Teramoto; Rouba Ali-Fehmi; Joanne K L Rutgers; Farah Tabassum; Denise Barbuto; Irene Aguilera-Barrantes; Alexandra Shaye-Brown; Dean Daya; Elvio G Silva
Journal:  Int J Gynecol Pathol       Date:  2013-11       Impact factor: 2.762

5.  Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.

Authors:  Charles M Quick; Taymaa May; Neil S Horowitz; Marisa R Nucci
Journal:  Int J Gynecol Pathol       Date:  2012-07       Impact factor: 2.762

6.  Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma.

Authors:  Guangming Han; Diana Lim; Mario M Leitao; Nadeem R Abu-Rustum; Robert A Soslow
Journal:  Histopathology       Date:  2013-11-12       Impact factor: 5.087

7.  Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

Authors:  Roel G W Verhaak; Pablo Tamayo; Ji-Yeon Yang; Diana Hubbard; Hailei Zhang; Chad J Creighton; Sian Fereday; Michael Lawrence; Scott L Carter; Craig H Mermel; Aleksandar D Kostic; Dariush Etemadmoghadam; Gordon Saksena; Kristian Cibulskis; Sekhar Duraisamy; Keren Levanon; Carrie Sougnez; Aviad Tsherniak; Sebastian Gomez; Robert Onofrio; Stacey Gabriel; Lynda Chin; Nianxiang Zhang; Paul T Spellman; Yiqun Zhang; Rehan Akbani; Katherine A Hoadley; Ari Kahn; Martin Köbel; David Huntsman; Robert A Soslow; Anna Defazio; Michael J Birrer; Joe W Gray; John N Weinstein; David D Bowtell; Ronny Drapkin; Jill P Mesirov; Gad Getz; Douglas A Levine; Matthew Meyerson
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

8.  Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.

Authors:  Sanjay Logani; Esther Oliva; Mahul B Amin; Andrew L Folpe; Cynthia Cohen; Robert H Young
Journal:  Am J Surg Pathol       Date:  2003-11       Impact factor: 6.394

9.  Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

Authors:  C Blake Gilks; Diana N Ionescu; Steve E Kalloger; Martin Köbel; Julie Irving; Blaise Clarke; Jennifer Santos; Nhu Le; Veronika Moravan; Kenneth Swenerton
Journal:  Hum Pathol       Date:  2008-07-07       Impact factor: 3.466

10.  Transitional cell carcinoma in high-grade high-stage ovarian carcinoma. An indicator of favorable response to chemotherapy.

Authors:  S S Robey; E G Silva; D M Gershenson; D McLemore; A el-Naggar; N G Ordonez
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

View more
  3 in total

1.  International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.

Authors:  Simona Stolnicu; Iulia Barsan; Lien Hoang; Prusha Patel; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kiyokawa; Isabel Alvarado-Cabrero; Malcolm C Pike; Esther Oliva; Kay J Park; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2018-02       Impact factor: 6.394

2.  Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas.

Authors:  Lauren L Ritterhouse; Jonathan A Nowak; Kyle C Strickland; Elizabeth P Garcia; Yonghui Jia; Neal I Lindeman; Laura E Macconaill; Panagiotis A Konstantinopoulos; Ursula A Matulonis; Joyce Liu; Ross S Berkowitz; Marisa R Nucci; Christopher P Crum; Lynette M Sholl; Brooke E Howitt
Journal:  Mod Pathol       Date:  2016-05-06       Impact factor: 7.842

3.  Multisite Tumor Sampling Reveals Extensive Heterogeneity of Tumor and Host Immune Response in Ovarian Cancer.

Authors:  Sotirios Lakis; Vassiliki Kotoula; Georgia-Angeliki Koliou; Ioannis Efstratiou; Sofia Chrisafi; Alexios Papanikolaou; Pantelis Zebekakis; George Fountzilas
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.